• 1
    Rogers WA, Donovan EF, Kociba GJ. Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoprotein-emia. J Am Vet Med Assoc 1975; 166:10921100.
  • 2
    Havel RJ, Goldstein JL, Brown MS. Lipoproteins and lipid transport. In: BondyPK, RosenbergLE, eds. Metabolic Control and Disease, 8th ed. Philadelphia : WB Saunders, 1980; 393494.
  • 3
    Grundy SM. Pathogenesis of hyperlipoproteinemia. J Lipid Res 1984; 25:16111618.
  • 4
    Baum D., Schweid AI, Porte D. Jr, et al. Congenital lipoprotein lipase deficiency and hyperlipemia in the young puppy. Proc Soc Exp Biol Med 1969; 131:183185.
  • 5
    Rogers WA, Donovan EF, Kociba GJ. Idiopathic hyperlipoproteinemia in dogs. J Am Vet Med Assoc 1975; 166:10871091.
  • 6
    Wada M., Minamisono T., Ehrhart LA, et al. Familial hyperlipoproteinemia in beagles. Life Sci 1977; 20:9991008.
  • 7
    Schaefer EJ, Levy RI. Pathogenesis and management of lipoprotein disorders. New Engl J Med 1985; 312:13001310.
  • 8
    Brunzell JD, Miller NE, Alaupovic P., et al. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res 1983; 24:1219.
  • 9
    Nikkila EA. Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism. In: StanburyJB, Wyngaar-denJB, FredricksonDS, et al, eds. The Metabolic Basis of Inherited Disease, 5th ed. St. Louis : McGraw-Hill, 1983; 622642.
  • 10
    Dunn FL, Grundy SM, Bilheimer DW, et al. Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia. Metabolism 1985; 34:316324.
  • 11
    Brunzell JD, Bierman EL. Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Med Clin North Am 1982; 66:455468.
  • 12
    Segal P., Rifkind BM, Schull WJ. Genetic factors in lipoprotein variation. Epidemiol Rev 1982; 4:137160.
  • 13
    Musiala TS, Dubin A.. Effects of chylomicrons and their removal on spectrophotometric analyses. Clin Chem 1977; 23:1121.
  • 14
    Snedcor GW, Cochran WG. Statistical Methods, 7th ed. Ames , Iowa : Iowa State University Press, 1980; 144146.
  • 15
    Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968; 6:168.
  • 16
    Manual of Laboratory Operations, Lipid Research Clinic Program. Lipid and Lipoprotein Analysis. 1974; DHEW (NIH) Publication No. 75–628.
  • 17
    Mahley RW, Weisgraber KH. Canine lipoproteins and atherosclerosis. I. Isolation and characterization of plasma lipoproteins from control dogs. Circ Res 1974; 35:713721.
  • 18
    Whitney MS, Boon GD, Rebar AH, et al. The effects of acute pancreatitis on circulating lipids in dogs. Am J Vet Res 1987; 48:14921497.
  • 19
    Havel RJ. The formation of LDL: mechanisms and regulation. J Lipid Res 1984; 25:15701576.
  • 20
    Oschry Y., Olivecrona T., Deckelbaum RJ, et al. Is hypertriglyceridemic very low density lipoprotein a precursor of normal low density lipoprotein. J Lipid Res 1985; 26:158167.
  • 21
    Dunn FL. Hyperlipidemia and diabetes. Med Clin North Am 1982; 77:13471360.
  • 22
    Greenberger NJ. Pancreatitis and hyperlipemia. N Engl J Med 1973; 289:586587.
  • 23
    Grundy SM. Hypertriglyceridemia: mechanisms, clinical significance, and treatment. Med Clin North Am 1982; 66:519535.